Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation

Moritz Hentschke1, Laura Berneking, Cristina Belmar Campos

  • 1Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Eppendorf, Hamburg, Germany. jbaltzer@mta.ca

Plos One
|October 20, 2010
PubMed
Abstract

Insights

Pathogenic Yersinia bacteria use the YopM effector protein to block the dephosphorylation of RSK kinases. This novel mechanism sustains RSK activation, aiding bacterial survival during infection.

Area of Science:

  • Microbiology
  • Cellular Biology
  • Immunology

Background:

  • Pathogenic Yersinia species inject effector proteins (Yops) into host cells to subvert immune responses and ensure bacterial survival.
  • YopM is a critical virulence factor, and its absence significantly reduces Yersinia's pathogenicity.
  • YopM has been previously implicated in forming complexes with and activating PKN2 and RSK1 kinases in host cells.

Purpose of the Study:

  • To investigate the interaction of YopM with protein kinases PKN and RSK in a near-physiological setting.
  • To elucidate the mechanism by which YopM influences RSK activity during Yersinia infection.
  • To explore the potential role of YopM in modulating host cell signaling pathways.

Main Methods:

  • Utilized a double-affinity-tagged YopM translocated into J774A.1 macrophages via Yersinia's type three secretion system.
  • Analyzed YopM interactions with PKN and RSK isoforms in transfected and infected cells.
  • Performed ATP-depletion assays and in vitro studies with purified components to assess phosphatase activity.

Main Results:

  • Confirmed YopM interaction with PKN2 and RSK1, and identified associations with additional PKN and RSK isoforms.
  • Demonstrated that YopM induces sustained RSK phosphorylation at activation sites (serine-380 and serine-221), independent of upstream signaling.
  • Showed that YopM directly inhibits RSK dephosphorylation by shielding RSK isoforms from phosphatase activity.

Conclusions:

  • YopM promotes sustained RSK activation during Yersinia infection by preventing the dephosphorylation of key activation sites.
  • This represents a novel mechanism employed by a bacterial virulence factor to manipulate host cell signaling.
  • The findings offer new insights into Yersinia pathogenesis and host-pathogen interactions.

Related Concept Videos

Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Plague01:24

Plague

Plague is a highly virulent zoonotic disease caused by Yersinia pestis, a Gram-negative, facultatively anaerobic coccobacillus. This pathogen primarily circulates among rodent populations and is transmitted to humans through the bite of infected fleas. Additional transmission routes include direct contact with infected animal tissue or inhalation of respiratory droplets from individuals with pneumonic plague. These multiple transmission pathways highlight the bacterium’s potential for rapid...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...